Effect of Exercise Training in Patients With Pulmonary Hypertension
1 other identifier
interventional
32
1 country
1
Brief Summary
Pulmonary Hypertension (PH) is a serious disease with a dismal prognosis when left untreated. Advances in medical therapy have improved survival according to recent registries and systematic reviews, but are associated with high healthcare costs. Earlier studies in Heidelberg, Germany showed good evidence for the effect of exercise training on improving exercise performance, quality of life and pulmonary hemodynamics in patients with pulmonary hypertension. The main objectives of the present project are:
- 1.to investigate the quality of the implementation of a standardized 3 week in-hospital exercise training program on markers of outcome and disease severity in PH-patients in Switzerland immediately after training and after 3 and 12 month.
- 2.to look whether training with hyperoxia vs. standard care might be more effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 14, 2015
CompletedFirst Posted
Study publicly available on registry
September 24, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedNovember 2, 2022
November 1, 2022
8.3 years
September 14, 2015
November 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
6 Minute walking test
Change from Baseline to 15 weeks
Constant cardiopulmonary exercise testing change in endurance time
Change from Baseline to 15 weeks
Secondary Outcomes (8)
Quality of Life (questionnaire)
Baseline, 3 weeks, 15 weeks, 6 and 12 months
Sit-to-Stand (physiological parameter)
Baseline, 3 weeks, 15 weeks, 6 and 12 months
Stair Ascent (physiological parameter)
Baseline, 3 weeks, 15 weeks, 6 and 12 months
Cognitive function (questionnaire)
Baseline, 3 weeks, 15 weeks, 6 and 12 months
Hemodynamic (physiological parameter)
Baseline, 3 weeks, 15 weeks, 6 and 12 months
- +3 more secondary outcomes
Other Outcomes (1)
Hospitalisation days
Baseline, 3 weeks, 15 weeks, 6 and 12 months
Study Arms (4)
Immediate Rehabilitation
EXPERIMENTALThe PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training.
Immediate Rehabilitation with oxygen
EXPERIMENTALThe PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training. Patients who are not already under long-term oxygen therapy (LTOT) due to daytime hypoxemia will additionally be randomized to receive standardized supplemental oxygen therapy (SSOT) during training and nights.
Delayed Rehabilitation
EXPERIMENTALWaiting group that participates in the rehabilitation program after 3 months. The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training.
Delayed Rehabilitation with oxygen
EXPERIMENTALWaiting group that participates in the rehabilitation program after 3 months. The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training. Patients who are not already under long-term oxygen therapy (LTOT) due to daytime hypoxemia will additionally be randomized to receive standardized supplemental oxygen therapy (SSOT) during training and nights.
Interventions
The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training.
The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training. Patients who are not already under long-term oxygen therapy (LTOT) due to daytime hypoxemia will additionally be randomized to receive standardized supplemental oxygen therapy (SSOT) during training and nights.
Eligibility Criteria
You may qualify if:
- WHO functional class II-IV
- PH diagnosed by right heart catheter showing:
- Baseline mean pulmonary arterial pressure (mPAP) ≥ 25 mmHg
- Baseline pulmonary vascular resistance (PVR) \> 240 dyn x s x cm-5
- Baseline pulmonary capillary wedge pressure (PCWP) ≤ 15 mm Hg
- Patients receiving maximal PH therapy including intensified treatment with diuretics and who have been stable for 2 months before entering the study
- PH target therapy should not be expected to change during the entire 15-week study period
- Negative pregnancy test (β-HCG) at the start of the trial
- Able to understand and willing to sign the Informed Consent Form
You may not qualify if:
- PH due to significant left heart disease (Wedge ≥ 15mmHg) or lung disease (FEV1 ≤ 60% predicted)
- Pregnancy at study onset
- Walking disability
- Any change in disease-targeted therapy within the last 2 months
- Any subject who is scheduled to receive another investigational drug during the course of this study
- Any other relevant concomitant disease
- Systolic blood pressure \< 85 mmHg
- History or suspicion of inability to cooperate adequately
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UniversityHospital Zurich, Department of Pulmonology
Zurich, 8091, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Silvia Ulrich Somaini, PD Dr.
UniversityHospital Zurich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2015
First Posted
September 24, 2015
Study Start
September 1, 2015
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
November 2, 2022
Record last verified: 2022-11